Bausch Health Companies, Inc. recalls Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg…
- Recall date
- February 2, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0355-2024
- FDA classification
- Class II
- Brand / firm
- Bausch Health Companies, Inc.
- Sold / distributed
- Nationwide
Why it was recalled
Subpotent Drug: Out of specification for assay
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.
Get recall alerts
Free email alert whenever Bausch Health Companies, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bausch Health Companies, Inc.